Gapping down
In reaction to earnings/guidance:
- CHWY -0.8%, PLAY -0.6%
Other news:
- AMRS -18.5% (after LAVVAN filed $881 mln lawsuit against co for patent infringement and trade secret misappropriation)
- SPRO -8.1% (prices offering of 4,785,000 shares of its common stock and 3,215,000 shares of its non-voting Series D Convertible Preferred Stock at $10.00)
- MNRL -7.7% (prices secondary offering of 4,366,209 shares of its Class A common stock by certain of its stockholders at a price to the public of $8.20 per share)
- QTNT -4.6% (prices offering of 17,647,059 ordinary shares at $4.25 per share)
- FOUR -2% (prices offering of 2,000,000 shares of its Class A common stock by co and 8,000,000 shares by certain selling stockholders at $48.50 per share)
- NTRA -1.6% (prices offering of 4,166,666 shares of its common stock at $60.00 per share)
- EDIT -1.3% (announces U.S. Patent and Trademark Office grants the Broad Institute priority benefit in CRISPR Interference)
- VRM -0.7% (prices offering of 10,800,000 shares of its common stock at $54.50 per share)
Analyst comments:
- STSA -10.3% (downgraded to Neutral from Outperform at Credit Suisse; downgraded to Neutral from Buy at Mizuho)
- BCC -1% (downgraded to Neutral from Buy at BofA Securities)